Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 2
2013 2
2014 7
2015 4
2016 8
2017 2
2019 2
2020 3
2021 6
2022 3
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
DPP8 Selective Inhibitor Tominostat as a Novel and Broad-Spectrum Anticancer Agent against Hematological Malignancies.
Kikuchi S, Wada A, Kamihara Y, Okazaki K, Jawaid P, Rehman MU, Kobayashi E, Susukida T, Minemura T, Nabe Y, Iwao N, Ozawa T, Hatano R, Yamada M, Kishi H, Matsuya Y, Mizuguchi M, Hayakawa Y, Dang NH, Sakamoto Y, Morimoto C, Sato T. Kikuchi S, et al. Among authors: kamihara y. Cells. 2023 Apr 6;12(7):1100. doi: 10.3390/cells12071100. Cells. 2023. PMID: 37048172 Free PMC article.
Protein-losing Enteropathy Complicated with Primary Intestinal Follicular Lymphoma.
Minemura T, Kikuchi S, Mihara H, Kamihara Y, Wada A, Fuchino M, Nanjo S, Noguchi A, Minamisaka T, Murakami J, Yasuda I, Sato T. Minemura T, et al. Among authors: kamihara y. Intern Med. 2022 Jul 1;61(13):2051-2055. doi: 10.2169/internalmedicine.8261-21. Epub 2021 Nov 27. Intern Med. 2022. PMID: 34840227 Free PMC article.
DPP8 is a novel therapeutic target for multiple myeloma.
Sato T, Tatekoshi A, Takada K, Iyama S, Kamihara Y, Jawaid P, Rehman MU, Noguchi K, Kondo T, Kajikawa S, Arita K, Wada A, Murakami J, Arai M, Yasuda I, Dang NH, Hatano R, Iwao N, Ohnuma K, Morimoto C. Sato T, et al. Among authors: kamihara y. Sci Rep. 2019 Dec 2;9(1):18094. doi: 10.1038/s41598-019-54695-w. Sci Rep. 2019. PMID: 31792328 Free PMC article.
Rituximab administration and reactivation of HBV.
Tsutsumi Y, Ogasawara R, Kamihara Y, Ito S, Yamamoto Y, Tanaka J, Asaka M, Imamura M. Tsutsumi Y, et al. Among authors: kamihara y. Hepat Res Treat. 2010;2010:182067. doi: 10.1155/2010/182067. Epub 2010 Dec 1. Hepat Res Treat. 2010. PMID: 21188195 Free PMC article.
Axicabtagene Ciloleucel in the Non-Trial Setting: Outcomes and Correlates of Response, Resistance, and Toxicity.
Jacobson CA, Hunter BD, Redd R, Rodig SJ, Chen PH, Wright K, Lipschitz M, Ritz J, Kamihara Y, Armand P, Nikiforow S, Rogalski M, Maakaron J, Jaglowski S, Maus MV, Chen YB, Abramson JS, Kline J, Budde E, Herrera A, Mei M, Cohen JB, Smith SD, Maloney DG, Gopal AK, Frigault MJ, Acharya UH. Jacobson CA, et al. Among authors: kamihara y. J Clin Oncol. 2020 Sep 20;38(27):3095-3106. doi: 10.1200/JCO.19.02103. Epub 2020 Jul 15. J Clin Oncol. 2020. PMID: 32667831 Free PMC article.
42 results